chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced the day after my arm swelled up, really fatigued, had no energy and had a bad headache and stomach pain. The stomach pain is still present. My headaches are a lot worse than ever before and it also has affected my eye sight which I never had before. I am waiting to see the eye specialist to hopefully I see him soon. What happened in my eye sight, my eye sight becomes out of focused and lose sight for a couple of minutes. I've never had problems with my eyes before the vaccine. My stomach pains are constant and I am also having mood swings which I did not have before. I am taking migraine medicine for my migraines which do not help bring the pain or headaches down. I do not remember which arm I put my vaccine in.
Patient had Syncopal (vasovagal) episode after receiving the first dose of Pfizer vaccine. Patient became pale, clammy and semi conscious for approximately 30 seconds. Patient was positioned in a semi fowlers position and ice packs were placed under the axilla. Patients vitals were obtained: Heart rate-52, Respirations-16, SpO2-95, BP-110/72. Patient was AAOx4 after interventions. Patient was given fruit snacks and water. Patient was assisted to the passenger side to recover. Patient's girlfriend was instructed to drive around and wait an additional 15 minutes. Patient was then observed, reassessed and refused further treatment from onsite medical staff.
swelling of tongue, metallic taste in mouth, instant frontal lobe headache and rash that appeared on my back 48 hours later- I took a benedryl and had my husband monitor me.  I was watched for 30 minutes at the site with my symptoms being manageable there and they got worse within the hour.  I am allergic to sulfa with mild reactions to it in small doses.  The tongue swelling, headache and metallic taste in my mouth were gone in 12 hours.
PATIENT PRESENTED WITH GENERALIZED REDNESS WITH RED SWELLINGS IN NECK, BODY, FACE AND BOTH UPPER LIMBS. PATIENT REFERS RASH AND ITCH IN THE BODY AND FELT HOT. THEY PROCEDED TO INJECT EPIPEN (EPINEPHRINE) IN THE RIGHT TIGH BUT THE PATIENT CONTINUED WITH THE REDNESS AND RASH (15 MINUTES LATER). HE WAS TAKEN TO THE EMERGENCY ROOM (HOSPITAL).
12/14 I was suffering from extremely mild cold symptoms and I tested to be safe and tested positive for COVID-19 on an at home test. Symptoms where very mild congestion, cough, post nasal drip, and fatigue. Symptoms were completely resolved by 12/16 and tested negative on 12/25.
Day 2: sore arm, blotchy rash at and below injection site, body aches, fatigue Days 3-6: head ache, body aches, fatigue, congestion, nausea
arm rash; This case was reported by a other health professional via call center representative and described the occurrence of rash in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th July 2019, the patient received the 1st dose of Shingrix .5 ml. In July 2019, less than a week after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were received as follows: The reporter stated that, the patient had the rash at the injection site on her left arm 4-5 days following the injection and had spread down the arm. The reporter consented to follow up.
Cough  Suspected COVID-19 virus infection  Clinical Support 4/30/2021  Dx Medication Infusion Reason for Visit Progress Notes Encounter Date: 4/30/2021 ? ? Signed    12:50 pm: -Patient arrived in the clinic for MAB infusion, reports that of late her BP has been fluctuating with periods of low BP and dizziness. VS stable.   12:56 pm: -Initial set of VS stable and patient reports no SOB.   0110 pm: -Commenced infusion.   01:33pm: -Infusion ended successfully with no adverse reactions. BP 95/59, no complains.Will monitor in clinic for 1 hour.   02:33pm: -Patient stable and VS acceptable BP 112/70.Educated on monitoring SpO2 at home and care navigators to make home follow up calls.Discharged home with daughter.      Instructions  COVID 19 Monoclonal Antibody (MAB) Infusion Patient Reference Guide
the right side of my face became numb/tingly; the right side of my face became numb/tingly; This is a spontaneous report from a contactable consumer.  A 51-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 04Mar2021 at 17:30 at single dose in right arm for COVID-19 immunisation at the age of 51-year-old. Lot number EN6202. Medical history included sleep apnea, asthma, allergy to sulfa, grass allergy, allergy to molds, Pollen allergy. The patient was not pregnant. Historical vaccine included TDAP on 18Feb2021 in right arm. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), fluticasone furoate (ARNUITY ELLIPTA), montelukast sodium (SINGULAIR), ergocalciferol (VIT D). The patient waited 30 minutes after injection because she did do get allergy injections so the patient was just being extra cautious. On 04Mar2021, at 18:15, after we left the right side of face became numb/ tingly. It lasted probably an hour. The patient was not treated due to the events. The patient recovered from the events on unknown date. No follow-up attempts are needed. No further information is expected
Throat stated to felt tight, lightheaded. Pt had COVID November 2020. More swollen under chin area and lymph nodes. Patient states her mouth feels dry.
Soreness and aching to left arm approximately 3hrs after vaccine. Nausea with dry heaves, body aches, sweats, extreme fatigue, and headache by 7:00 am the next day.
Information has been received from a physician concerning a female patient in her mid teens with a fear of needles who on approximately 08-JUN-2009 was vaccinated with GARDASIL (dose, route and lot # not reported). The physician reported that after receiving GARDASIL the patient fainted and hit her head on the table which caused her to have a laceration on her forehead. The physician reported that the patient came back a week later (approximately 15-JUN-2009) to the office and "potentially had a concussion" because the patient was "a little bit confused". The patient sought medical attention through an office visit. The patient's outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
experienced some slight itching; This case was reported by a consumer and described the occurrence of injection site itching in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pruritus (received 1st dose on unknown date, refer case US2021026215). Concurrent medical conditions included drug hypersensitivity (to Depo-Medrol).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced injection site itching. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site itching was recovered/resolved.   The reporter considered the injection site itching to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient could not remember the exact dates of when she received the vaccine but believed it to be last year or possibly 2019. The patient experienced some slight itching the following day that lasted several weeks and experienced no other reactions.   Did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021026215:same reporter
Information has been received from a physician concerning a 17 year old female who was vaccinated with the third dose of Gardasil. Subsequently, the patient experienced "numbness and tingling of her extremities, as well as fatigue". The patient told her mother this after receiving all three doses of Gardasil. It was unspecified when the patient started experiencing these conditions. As of 13-JUL-2007, the outcome of the patient's numbness and tingling of her extremities and fatigue was unknown. Additional information has been requested.  No further information is available.
Fever, total body aches, nausea, fatigue, elevated B/P and tachycardia, epistaxis;  Serum sickness.
Approximately 2 weeks after vaccine, I had dry eye. My eyes were stinging. I went to my primary care physician then referred to an eye care specialists. The outcome was unknown. I was advised to use OTC eye drops. I still have the issue but is relieved by eye drops.
vaccine administered 21 days after 1st punctured; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine administered 21 days after 1st punctured) in a 19-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine administered 21 days after 1st punctured). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine administered 21 days after 1st punctured) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was provided. No treatment medication details was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Translation received on 29-Sep-2021 contain Non significant information.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 73-year-old male patient who received Shingrix (batch number 27K24, expiry date 22nd February 2021) for prophylaxis. Previously administered products included Shingrix with an associated reaction of injection site pain (1st dose received on 29th June 2018,for tolerance see case US2018148542). On 14th August 2018, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 14th August 2018, less than a day after receiving Shingrix, the patient experienced injection site pain and drug dose administration interval too short. On 15th August 2018, the patient experienced muscle soreness. The patient was treated with Advil. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain and muscle soreness were recovering/resolving and the outcome of the drug dose administration interval too short was unknown. It was unknown if the reporter considered the injection site pain and muscle soreness to be related to Shingrix. Additional details were provided as follows: This case was previously reported to the doctor. The patient stated that he was called back to get his 2nd dose 30 days after the first dose of Shingrix. The patient returned to the facility yesterday (the day before reporting) on 14th August 2018, 45 days after the first, and was given the 2nd dose of Shingrix, which led to shortening of vaccination schedule. On the day of reporting, the patient woke up with muscle soreness of his neck and shoulders. The patient was taking Advil for the soreness and had reported it to his physician, who referred him to GSK on the early dose. The healthcare professional information not asked. This case has been linked with case US2018148542 (same patient), reported by the same reporter.
The 3rd day I had redness on my skin the next day I had all over the body. At night I notice the hands swollen. I went to the ER. They gave me medicine thru IV and it went away, but the next day I was more swollen and redness all over. I went back to ER and they gave me more medicine thru IV the redness stain was fading. The other day in the afternoon it still came back. The forth time I went back to ER and every time I went I was even more swollen with stains of redness all over my body. After that they sent him to another ER because they didn't know what else to do. At the hospital I saw a dermatologist and they gave me medicine and it was getting better. They sent me home with medicine and it was working and kept taking it until it all went away.
Pt presented with an elevated blister , purpura color down the injection site, blister were like to inches down /back were immunization was administered. Patient presented to the pharmacy 2 days after. recommended to see Dr and start taking antihistamines
low grade fever; generalized aching; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PYREXIA (low grade fever) and PAIN (generalized aching) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    No Medical History information was reported.   In August 2019, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram. On 21-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced PYREXIA (low grade fever) and PAIN (generalized aching). At the time of the report, PYREXIA (low grade fever) and PAIN (generalized aching) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
I received my 5th Moderna Covid-19 vaccine on 9-7-22. On 9-27-22 I developed moderate nasal congestion & sneezing; treated successfully with a nasal decongestant. I was fatigued on 9-28 and 9-29 developed cough & mild sore throat. A week before I had been exposed to family members with a cold who tested negative for covid and assumed I caught what they had; when the cough started and my husband (who also had the Covid vaccine on 9-7 at a different pharmacy) started feeling sick too we both tested for covid and were both positive on 9-29. We were treated with Paxlovid and got 90% better in a few days, but on the evening of October 11 (day 8 after Paxlovid) we started feeling sick again with cough & runny nose.
Blistery rash approximately 2x2" surrounded by erythema Rash/blisters appeared 2/26/10 with erythema/induration since several hours after vaccine.
Parents report her (L) eye is appearing "droopy" since this AM. She has been crying & rubbing that eye. They deny discharge, conjunctival redness, not facial asymmetry. On exam no conjunctival infection, tearing, discharge, or facial asymmetry. No treatment required. She received 2 doses of DTap yesterday.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Sep2021 as dose 3 (booster), single (Lot number: 533592) and on 16May2022 as dose 4 (booster), single (Lot number: FJ4989) at the age of 67 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diagnosed with COVID" (unspecified if ongoing), notes: Diagnosed with COVID on 25Jul tested on 24th when symptoms started.; "Hypothyroidism" (unspecified if ongoing), notes: Hypothyroidism complex regional pain syndrome with neuropathy right foot post fracture; "Just tumor" (unspecified if ongoing); "IBS" (unspecified if ongoing); "Known allergies: multiple food sensitivities- GI issues" (unspecified if ongoing), notes: multiple food sensitivities-GI issues; "neuropathy right foot post fracture" (unspecified if ongoing), notes: Hypothyroidism complex regional pain syndrome with neuropathy right foot post fracture; "right foot post fracture" (unspecified if ongoing), notes: Hypothyroidism complex regional pain syndrome with neuropathy right foot post fracture; "regional pain syndrome" (unspecified if ongoing), notes: Hypothyroidism complex regional pain syndrome with neuropathy right foot post fracture. There were no concomitant medications. Past drug history included: Tetracycline, reaction(s): "Known allergies: Tetracycline"; Demerol, reaction(s): "Known allergies: Demerol causes acute hallucination"; Minocin, reaction(s): "Known allergies: Minocin". The patient was not received other medication in 2 weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19 which includes Paxlovid start and stop on 25Jul2022.
shingles after getting the booster; This spontaneous case was reported by an other health care professional and describes the occurrence of HERPES ZOSTER (shingles after getting the booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles after getting the booster). At the time of the report, HERPES ZOSTER (shingles after getting the booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided.
7/3--Patient began to have involuntary eye "twitches" almost like a surprised look and he was unaware that he was doing this--this symptom noticeably lasted until around August 7th and sporadically thereafter--patient also experience changes in mood and irritability throughout this time; June 13th wet bed--excessively thirty--ER Visit due to high sugar (221):  07/25--Patient began complaining of headache in the center of his forehead; weakness on right side of his body; "funny" feeling in his stomach--episode lasted 45 minutes to an hour--resulted in ER visit;--Made followup appt with PCP;  07/26/2011--Patient again had same exact episode of previous day; 07/27/2011--Patient had same exact episode of previous day; 8/2--Followup visit w/PCP--thought maybe eye movement was possible "seizures" and ordered MRI and lab work: 8/3--MRI; 8/4--Lab Work:  8/5--Lab work looked good; however MRI showed abnormal FOCI in gray/white matter; demylination; vasculitis; lesion, etc;---waiting to get him into specialist; 8/11--Patient experience a pain in the middle of his forehead (he describes as someone pushing out his forehead) which almost knocked him to the ground--Parent and grandparent transported him to ER where he was admitted into the hospital; 8/12--Patient was sedated and given an Lumbar Puncture and was also given a EEG--discharged from hospital with medication and followup appt with Ped Neurologist on 8/30; 8/30--Dr. reported that EEG was normal and lab work was good--followup up with MRI and MRA on 11/17/2011 and continue with medication with dosage cut in half due to making patient too sleepy.
I have dermal fillers in my lips and chin. I received my lip filler 3 weeks prior to vaccination and they did not swell the next day. My chin filler that I received in beginning of December 2020 did swell the next day and is slightly painful to touch.
Information has been received from a health professional concerning a 6 year old male's father who on approximately 05-SEP-2007 was squirted with varicella virus vaccine live (Oka/Merck) into his eyes when his son who was being vaccinated, moved. The father experienced stinging to his eyes. His eyes were flushed at the office. The outcome is reported as recovered. Unspecified medical attention was sought. There was no product quality complaint. This is one report of several from the same source. Additional information has been requested. 3/25/2010 Follow up from a registered nurse indicated that no additional information was available. Additional information is not expected.
a severe headache; close to a migraine for almost 10 days; she is in tears; pain has been from a 1-10 scale from 10 to 6; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (a severe headache), MIGRAINE (close to a migraine for almost 10 days), CRYING (she is in tears) and PAIN (pain has been from a 1-10 scale from 10 to 6) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (a severe headache), MIGRAINE (close to a migraine for almost 10 days), CRYING (she is in tears) and PAIN (pain has been from a 1-10 scale from 10 to 6). At the time of the report, HEADACHE (a severe headache), MIGRAINE (close to a migraine for almost 10 days), CRYING (she is in tears) and PAIN (pain has been from a 1-10 scale from 10 to 6) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
On 1.26.19 called on call dr - mother says patient feels hot & shivering & vomited Tylenol. Advised: cool rag to head. offer Tylenol after clear liquids tolerated. Call back if no better. 1.28.19 - spoke with mom & patient is much better. No fever or vomiting.
Eventual polymyalgia rheumatica diagnosed 9/2017. Started with site arm arthralgia then spread to both arms and then global over time. No official notification to Employee Health until 10/17/17 when he came to sign a declination for this year's vaccine.
Woke up 2 days after receiving 4 month of age immunizations with a brightened raised rash from neck to diaper area with low grade fever. No breathing problems and no local reaction to vaccines. No treatment other than tylenol and gone the next day.
Induration 25 x 30 mm on LA where VARIVAX given pt. complaining pain no itchiness. Also, pt. RA where MMR given redness only no induration. Pt. no complaint. Mom notice yesterday.
Difficulty swallowing, sensation of something stuck in throat and chest and have had since shot. Several Doctor appointments regarding this.
Information has bee received from a physician concerning a 65 year old female who on 26-FEB-2008 was vaccinated in the left arm with a single dose series of zoster vaccine live (Oka/Merck) (lot # 659326/1824U). There was no illness at the time of vaccination. The physician reported that the patient has been complaining ever since receiving the vaccination of severe pain and discomfort in the arm that she received the vaccination in. Medical attention was sought, the patient called the physician. There were no lab studies performed. The physician reported that the patient had just called in everyday for the past two weeks about pain she was having. The patient was advised to put hydrocortisone on her arm and to take TYLENOL. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Follow-up information from the physician's office indicated the patient reported pain, swelling, and redness at the site which stared on 27-Feb-2008. The patient was not actually seen by the physician. Additional information has been requested.